Read this about IGXT (MarketCap $30 Mil) 2 Drugs under review by FDA
IntelGenx (IGXT :$0.60) – Drug Delivery company focused on Oral method with strong pipeline of pharma drugs
Targets: Near term: $2 – $3 /// Long term: $5+
6th August, 2013
New HOT Stock pick: IntelGenx Corp. (IGXT: $0.60)
IntelGenx has an FDA approved drug (Fortivo XL) on the market and several in pipeline for various indications with multi billion dollar market for some of the other approved drugs on the market for the treatments. Company has many good partnerships in place with companies like PAR Pharma, RedHill BioPharma, Edgemont Pharmaceuticals and others.
IntelGenx is uniquely positioned to capture a huge marketshare given its large portfolio of patents in Drug Delivery Systems. It has 3 key methods:
1) VersaTab – Controlled release tablets
2) VersaFilm – Rapidly disintegrating film
3) AdVersa – Mucoadhesive tablet
Company has NO debt and has sufficient cash for near term giving its current burn rate.
Current capital structure includes:
Shares outstanding: 58 Million
Insider Ownership: 22%